Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.
31
A rare tumor called primary central nervous system lymphoma was two times more likely to be found in blacks ages 20 to 49 than whites, U.S. researchers said.
30
The Leukemia & Lymphoma Society (LLS) and FORMA Therapeutics announced a partnership to accelerate LLS's pipeline of research projects entering late pre-clinical development.
California and Arizona researchers have identified a gene variant that carries nearly twice the risk of developing an increasingly common type of blood cancer, according to a study published online today by the science journal Nature Genetics.
27
The Multiple Myeloma Research Foundation (MMRF) and Multiple Myeloma Research Consortium (MMRC) today announced the MMRC Multiple Myeloma Genomics Initiative has completed the sequencing of the first multiple myeloma whole genomes. This is the first time multiple myeloma whole genomes have been sequenced and will be used to identify key targets for new treatments.
23
Researchers detail in 'Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma,' new data in lymphoma. Most patients with Hodgkin lymphoma (HL) are cured with first and second-line treatment; however, the outcome is unknown for those who fail high dose chemoradiotherapy with autologous stem cell transplant (HDT-ASCT).
06
The Leukemia & Lymphoma Society (LLS) and The International Waldenstrom's Macroglobulinemia Foundation (IWMF) have partnered in an initiative to develop stable and immortalized Waldenstrom's macroglobulinemia (WM) cell lines that would be made widely available to researchers to test potential new treatments for the disease.
02
The Multiple Myeloma Research Consortium (MMRC), an innovative research model comprised of a network of 15 academic Member Institutions across North America and leadership in Norwalk, Connecticut, announced preliminary data from an analysis showing that clinical trials opened through its clinical trials network were activated 30 to 40 percent faster than comparable clinical trials in oncology.
29
Ablynx, a pioneer in the discovery and development of Nanobodies(R), a novel class of antibody-derived therapeutic proteins, today announced that it has advanced ALX-0061, a new Nanobody(R)-based therapeutic programme, into preclinical development for the treatment of autoimmune and inflammatory diseases.
25
The University of Pittsburgh Cancer Institute (UPCI) and the Gamida Cell - Teva Joint Venture announced that the Institute has joined an elite group of cancer centers in Europe, the United States and Israel that are now enrolling patients to participate in the ExCell research study.
Patients treated for Hodgkin lymphoma with radiation therapy have a substantially higher risk of stroke, according to a new study published June 17 online in the Journal of the National Cancer Institute. The study was undertaken because information on clinically verified stroke and transient ischemic attack (TIA), or a mini stroke, following Hodgkin lymphoma is limited
We care about your feedback. Let us know how we can improve your CancerCompass experience.